190 related articles for article (PubMed ID: 18462564)
1. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
Bailey W; Castro M; Matz J; White M; Dransfield M; Yancey S; Ortega H
Curr Med Res Opin; 2008 Jun; 24(6):1669-82. PubMed ID: 18462564
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
Katial RK; Bernstein D; Prazma CM; Lincourt WR; Stempel DA
Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
[TBL] [Abstract][Full Text] [Related]
7. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC; Lindemann L; Braun R; Steinkamp G
Swiss Med Wkly; 2004 Jan; 134(3-4):50-8. PubMed ID: 14745658
[TBL] [Abstract][Full Text] [Related]
9. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
Kuna P
Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
[TBL] [Abstract][Full Text] [Related]
10. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W; Goryachkina L; Jacques L; Frith L
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS; Wolfe JD; Gross G; Greos LS; Baitinger L; Scott C; Dorinsky P
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[TBL] [Abstract][Full Text] [Related]
12. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
Renzi PM; Howard LA; Ortega HG; Ahmad FF; Chapman KR
Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
14. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
Busse W; Koenig SM; Oppenheimer J; Sahn SA; Yancey SW; Reilly D; Edwards LD; Dorinsky PM
J Allergy Clin Immunol; 2003 Jan; 111(1):57-65. PubMed ID: 12532097
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
Hanania NA; Darken P; Horstman D; Reisner C; Lee B; Davis S; Shah T
Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
[TBL] [Abstract][Full Text] [Related]
18. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
Hagiwara M; Delea TE; Stanford RH; Stempel DA
Allergy Asthma Proc; 2010; 31(3):203-10. PubMed ID: 20534183
[TBL] [Abstract][Full Text] [Related]
19. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
[TBL] [Abstract][Full Text] [Related]
20. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
